References
- BalayanMSEvidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral routeIntervirology198320 23 3110.1159/000149370
- KamarNHepatitis E virus and chronic hepatitis in organ-transplant recipientsN. Engl. J. Med.200835881181710.1056/NEJMoa0706992
- SmithDBConsensus proposals for classification of the family HepeviridaeJ. Gen. Virol.2014952223223210.1099/vir.0.068429-04165930
- Anonymous.Hepatitis E virus: opinions of the Working Group of the Federal Ministry of Health BloodBundesgesundheitsblatt. Gesundh. Gesundh.20155819821810.1007/s00103-014-2103-4
- BoxallETransfusion-transmitted hepatitis E in a ‘nonhyperendemic’ countryTransfus. Med.200616798310.1111/j.1365-3148.2006.00652.x
- ColsonPTransfusion-associated hepatitis E, FranceEmerg. Infect. Dis.20071364864910.3201/eid1304.0613872725983
- Huzly, D. et al. Transfusion-transmitted hepatitis E in Germany, 2013. Euro. Surveill. 19, pii: 20812 (2014).
- PischkeSHepatitis E in Germany—an under-reported infectious diseaseDtsch. Arztebl. Int.20141115775834174681
- IjazSIndigenous hepatitis E virus infection in England: more common than it seemsJ. Clin. Virol.20094427227610.1016/j.jcv.2009.01.005
- HolmDKDeclining prevalence of hepatitis E antibodies among Danish blood donorsTransfusion2015551662166710.1111/trf.13028
- WenzelJJDecline in hepatitis E virus antibody prevalence in southeastern Germany, 1996-2011Hepatology2014601180118610.1002/hep.27244
- FaberMHepatitis E virus seroprevalence, seroincidence and seroreversion in the German adult populationJ. Viral Hepat.20182575275810.1111/jvh.12868
- HogemaBMMolierMSlotEZaaijerHLPast and present of hepatitis E in the NetherlandsTransfusion2014543092309610.1111/trf.127334280434
- ZaaijerHLNo artifact, hepatitis E is emergingHepatology20156265410.1002/hep.27611
- MansuyJMA nationwide survey of hepatitis E viral infection in French blood donorsHepatology2016631145115410.1002/hep.28436
- XuCAn assessment of hepatitis E virus (HEV) in US blood donors and recipients: no detectable HEV RNA in 1939 donors tested and no evidence for HEV transmission to 362 prospectively followed recipientsTransfusion2013532505251110.1111/trf.123264542147
- IjazSNon-travel-associated hepatitis E in England and Wales: demographic, clinical, and molecular epidemiological characteristicsJ. Infect. Dis.20051921166117210.1086/444396
- LangeHHepatitis E in Norway: seroprevalence in humans and swineEpidemiol. Infect.201714518118610.1017/S0950268816002144
- SchielkeAHepatitis E virus antibody prevalence in hunters from a district in Central Germany, 2013: a cross-sectional study providing evidence for the benefit of protective gloves during disembowelling of wild boarsBMC Infect. Dis.20151510.1186/s12879-015-1199-y4619084
- Krems, C., Walter, C., Heuer, T. & Hoffmann, I. Nationale Verzehrsstudie II—Lebensmittelverzehr und Naehrstoffzufuhr auf Basis von 24h-Recalls. https://www.mri.bund.de/fileadmin/MRI/Institute/EV/Lebensmittelverzehr_N%C3%A4hrstoffzufuhr_24h-recalls-neu.pdf (2013).
- WenzelJJDetection of hepatitis E virus (HEV) from porcine livers in Southeastern Germany and high sequence homology to human HEV isolatesJ. Clin. Virol.201152505410.1016/j.jcv.2011.06.006
- LapaDCapobianchiMRGarbugliaAREpidemiology of hepatitis E virus in European countriesInt. J. Mol. Sci.201516257112574310.3390/ijms1610257114632823
- Hartl, J. et al. Hepatitis E seroprevalence in Europe: a meta-analysis. Viruses8, pii: E211 (2016).
- PasSDDiagnostic performance of selected commercial HEV IgM and IgG ELISAs for immunocompromised and immunocompetent patientsJ. Clin. Virol.20135862963410.1016/j.jcv.2013.10.010
- BendallREllisVIjazSThurairajahPDaltonHRSerological response to hepatitis E virus genotype 3 infection: IgG quantitation, avidity, and IgM responseJ. Med. Virol.2008809510110.1002/jmv.21033
- SchemmererMRauhCJilgWWenzelJJTime course of hepatitis E-specific antibodies in adultsJ. Viral Hepat.201724757910.1111/jvh.12621
- BendallREllisVIjazSAliRDaltonHA comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countriesJ. Med. Virol.20108279980510.1002/jmv.21656
- ZhangJProtection against hepatitis E virus infection by naturally acquired and vaccine-induced immunityClin. Microbiol. Infect.201420O397O40510.1111/1469-0691.12419
- AdlhochCHepatitis E virus: assessment of the epidemiological situation in humans in Europe, 2014/15J. Clin. Virol.20168291610.1016/j.jcv.2016.06.010
- HuangSProfile of acute infectious markers in sporadic hepatitis EPLoS ONE20105e1356010.1371/journal.pone.00135602958841
- PurdyMAKhudyakovYEEvolutionary history and population dynamics of hepatitis E virusPLoS ONE20105e1437610.1371/journal.pone.00143763006657
- NakanoTNew findings regarding the epidemic history and population dynamics of Japan-indigenous genotype 3 hepatitis E virus inferred by molecular evolutionLiver. Int.20123267568810.1111/j.1478-3231.2011.02728.x
- LewisHCWichmannODuizerETransmission routes and risk factors for autochthonous hepatitis E virus infection in Europe: a systematic reviewEpidemiol. Infect.201013814516610.1017/S0950268809990847
- FaberMSHepatitis E virus seroprevalence among adults, GermanyEmerg. Infect. Dis.2012181654165710.3201/eid1810.1117563471611
- WenzelJJPreissJSchemmererMHuberBJilgWTest performance characteristics of Anti-HEV IgG assays strongly influence hepatitis E seroprevalence estimatesJ. Infect. Dis.201320749750010.1093/infdis/jis688
- FaulFErdfelderELangAGBuchnerAG*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciencesBehav. Res. Methods20073917519110.3758/BF03193146